当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › CURRENT OPINION IN BIOTECHNOLOGY杂志
CURRENT OPINION IN BIOTECHNOLOGY
基本信息
期刊名称 CURRENT OPINION IN BIOTECHNOLOGY
CURR OPIN BIOTECH
期刊ISSN 0958-1669
期刊官方网站 http://www.journals.elsevier.com/current-opinion-in-biotechnology/
是否OA
出版商 Elsevier Ltd
出版周期 Bimonthly
始发年份 1990
年文章数 147
最新影响因子 9.74(2020)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
工程技术1区 BIOCHEMICAL RESEARCH METHODS 生化研究方法1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物1区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 8.45 2.802 1.966
Engineering
Biomedical Engineering
8 / 205 96%
Biochemistry, Genetics and Molecular Biology
Biotechnology
11 / 257 95%
Chemical Engineering
Bioengineering
11 / 139 92%
补充信息
自引率 2.30%
H-index 181
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0958-1669%5BISSN%5D
投稿指南
期刊投稿网址 https://www.evise.com/evise/faces/pages/login/login.jspx?resourceUrl=%2
收稿范围

Current Opinion in Biotechnology (COBIOT) publishes authoritative, comprehensive, and systematic reviews. COBIOT helps specialists keep up to date with a clear and readable synthesis on current advances biotechnology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance. 

Current Opinion in Biotechnology is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Biotechnology (CRBIOT). CO+RE journals leverage the Current Opinion legacy?of editorial excellence, high-impact, and global reach?to ensure they are a widely read resource that is integral to scientists? workflow. 

Current Opinion in Biotechnology is divided into themed sections, each of which is reviewed once a year. Themes include analytical biotechnology; plant biotechnology; food biotechnology; energy biotechnology; environmental biotechnology; systems biology; nanobiotechnology; tissue, cell and pathway engineering; chemical biotechnology; and pharmaceutical biotechnology. 

The journal builds on Elsevier?s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.

  • Expertise ? Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant.
  • Comprehensiveness ? There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry.
  • Impact ? In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores.



Selection of topics to be reviewed 
Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. 

Reviews
Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year. 

Review articles in Current Opinion in Biotechnology are by invitation only. 

Editorial Overview
Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments. 

Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. 


收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息
Editor-in-Chief

Greg Stephanopoulos

Massachusetts Institute of Technology, Cambridge, Massachusetts, United States

Jan Roelof van der Meer

University of Lausanne, Lausanne, Switzerland
Editorial Board

Lilia Alberghina

University of Milan–Bicocca, Milano, Italy

Maciek Antoniewicz

University of Delaware, Newark, Delaware, United States
Edward BayerWeizmann Institute of Science Department of Biomolecular Sciences, Rehovot, Israel
George Guo-Qiang ChenTsinghua University, Beijing, China

Nam-Hai Chua

The Rockefeller University Plant Molecular Biology Laboratory, New York, New York, United States

Jiri Damborsky

Masaryk University, Brno, Czech Republic

Julian Davies

The University of British Columbia Department of Microbiology & Immunology, Vancouver, British Columbia, Canada

Luis Angel Fernandez

Spanish Scientific Research Council, Madrid, Spain

Alain Filloux

Imperial College London, London, United Kingdom

Matthias Heinemann

University of Groningen, Groningen, The Netherlands
Braunschweig University of Technology, Braunschweig, Germany

Lee Hood

Institute for Systems Biology, Seattle, Washington, United States

Karl-Erich Jaeger

Heinrich Heine University Düsseldorf Department of Molecular Enzymtechnology, Jülich, Germany

Janet Jansson

E O Lawrence Berkeley National Laboratory, Berkeley, California, United States

Mattheos Koffas

Rensselaer Polytechnic Institute, Troy, New York, United States

Kazuhiro Kogure

The University of Tokyo Atmosphere and Ocean Research Institute, Nakano-Ku, Japan
Sang Yup Lee

Sang Yup Lee

Korea Advanced Institute of Science and Technology Department of Chemical and Biomolecular Engineering, Daejeon, Korea, Republic of

Marcial L. Lizarraga-Partida

CICESE, Biotecnologia Mariana, San Diego, California, United States

Victor de Lorenzo

Spanish Scientific Research Council, Madrid, Spain

Joachim Messing †

Waksman Institute of Microbiology, Piscataway, New Jersey, United States

Beat Mollet

Nestle Research Center, Lausanne 26, Switzerland

Elke Nevoigt

Jacobs University Bremen gGmbH, Bremen, Germany

Robin Offord

Mintaka Foundation for Medical Research, Plan Les Ouates, Switzerland

Sven Panke

Swiss Federal Institute of Technology Department of Biosystems Science and Engineering, Basel, Switzerland

Carla Pruzzo

University of Genoa, Genova, Italy

Juan Ramos

Del Zaidin Experimental Station, Granada, Spain

Eugene Rosenberg

Tel Aviv University, Tel Aviv, Israel

Ian Rowland

University of Reading, Reading, United Kingdom

Athanassios Sambanis

Georgia Institute of Technology, Atlanta, Georgia, United States

Ka-Yiu San

Rice University, Houston, Texas, United States

Jacqueline Shanks

Iowa State University, Ames, Iowa, United States

Allan Shatzman

GlaxoSmithKline USA, King of Prussia, Pennsylvania, United States

Willem de Vos

Wageningen University, Wageningen, Netherlands

Daniel Wang

Massachusetts Institute of Technology, Cambridge, Massachusetts, United States

Wilfried Weber

University of Freiburg, Freiburg im Breisgau, Germany


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug